EU Manufacturer
🇪🇸 Spain
Active
Blackhills Diagnostic Resources S.L.U.
SRN: ES-MF-000001091
·
Camino del Pilón 86, 50011 Zaragoza, Spain
Basic UDI-DIs
48
Total Devices
70
On Market
70
Off Market
0
Certificates
1
Valid
0
Expiring < 6mo
0
Countries
32
Basic Information
- Address
- Camino del Pilón 86, 50011 Zaragoza, Spain
- [email protected]
- Website
- https://www.bdrdiagnostics.com/
Regulatory Overview
Regulation
Loading...
Eu Ivdd
28
Eu Ivdr
20
Classification
Loading...
Eu Ivd General
26
Eu Ivd Class C
20
Eu Ivd Annex 2 List B
2
Device Types
Loading...
Certificate Health
Total
1
Valid
0
Expiring < 6mo
0
Expired / Withdrawn
1
Certificates by Expiry Year
Loading...
| Type | Number | Expiry Date | Status | |||
|---|---|---|---|---|---|---|
| IVDD Annex IV (excluding sections 4, 6) | CE 588493 | BSI Group The Netherlands B.V. | May 26, 2025 |
Market Presence
Devices from this manufacturer are available in 32 countries across Europe.
🇦🇹 Austria
🇧🇪 Belgium
🇧🇬 Bulgaria
🇨🇾 Cyprus
🇨🇿 Czechia
🇩🇪 Germany
🇩🇰 Denmark
🇪🇪 Estonia
🇬🇷 Greece
🇪🇸 Spain
🇫🇮 Finland
🇫🇷 France
🇭🇷 Croatia
🇭🇺 Hungary
🇮🇪 Ireland
🇮🇸 Iceland
🇮🇹 Italy
🇱🇮 Liechtenstein
🇱🇹 Lithuania
🇱🇺 Luxembourg
🇱🇻 Latvia
🇲🇹 Malta
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇪 Sweden
🇸🇮 Slovenia
🇸🇰 Slovakia
🇹🇷 Türkiye
🇬🇧 United Kingdom
Device Portfolio
| Name | ||||
|---|---|---|---|---|
| Adellgene® Myotonic Dystrophy Screening 16 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Adellgene® Fragile X 100 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Adellgene® Fragile X 25 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Adellgene® Fragile X Screening 16 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Adellgene® Fragile X Screening 48 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Adellgene® Friedreich's Ataxia 16 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Adellgene® Huntington Disease 16 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Adellgene® Myotonic Dystrophy Confirmatory 16 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Adellgene® SCAs 16 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® MTHFR C677T 96 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® FIIFV multiplex 24 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® FIIFV multiplex 48 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® FIIFV multiplex 96 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® Factor II G20210A 24 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® Factor II G20210A 48 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® Factor II G20210A 96 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® Factor V G1691A 24 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® Factor V G1691A 48 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® Factor V G1691A 96 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE C282Y 24 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE C282Y 48 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE C282Y 96 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE H63D 24 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE H63D 48 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE H63D 96 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HFE S65C 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HFE S65C 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HFE S65C 96 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HFE multiplex 24 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HFE multiplex 48 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HFE multiplex 96 test | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA A29 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA A29 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA B27v5 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA B27v5 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA B57v5 24 tests | EU IVDD | Eu Ivd Annex 2 List B | On Market | 1 |
| Genvinset® HLA B57v5 48 tests | EU IVDD | Eu Ivd Annex 2 List B | On Market | 1 |
| Genvinset® HLA Behçet v5 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA Behçet v5 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA C*06 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA C*06 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA Celiac 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA Celiac 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA Celiac Plus 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA Celiac Plus 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA DQA1*05 24 tests | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HLA DQA1*05 48 test | EU IVDD | Eu Ivd General | On Market | 1 |
| Genvinset® HLA DQB1*03:02 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA DQB1*03:02 48 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |
| Genvinset® HLA Narcolepsy 24 tests | EU IVDR | Eu Ivd Class C | On Market | 0 |